Publication: 502

Publication: 502

Results of a phase II trial of vorinostat in patients with recurrent glioblastoma: Evidence of post-treatment histone acetylation in tumor tissue and pharmacokinetic analysis: North Central Cancer Treatment Group (NCCTG) study N047B

Google Scholar

Citation:

Meeting Instance:: TAT 2007
Year:: 2007
Type:: Abstract
Sub type:: Poster General
Funding:: NCTN
Endpoint:: Primary
Analysis:: Primary
Data Sharing:: No-Data-Sharing
Status:: Presented/Published
Citation Status:

Note:

Methodological:: No
Biospecimen:: No
SDC:: No

Parents:: None
Children:: 284

Program:: OGC
Primary Committee:: Neuro-Onc
Sec. Committees:

Pharmas:
Grants:

Corr. Author:
Authors:: K. Jaeckle M. Maurer J. Reid M. Ames C. Giannini D. Moore J. Zwiebel J. Buckner E. Galanis

Networks:

Study: NCCTG-N047B
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:: 2

Keywords: